Patrick J. Parks, MD, PhD

Adjunct Associate Professor, Department of Experimental and Clinical Pharmacology (ECP)
Patrick J. Parks Headshot



Adjunct Associate Professor, Department of Experimental and Clinical Pharmacology (ECP)
Medical Director, 3M Skin & Wound Care Division


Residency, Anatomic and Clinical Pathology, University Hospitals of Cleveland-Case Western Reserve University

Fellowship, Special Fellow in Immunopathology, Cleveland Clinic Foundation-Cleveland Clinic

PhD, Biomedical Engineering-Biomaterials Track, Case Western Reserve University

BS in Chem Engr, Chemical engineering, University of Pittsburgh

Expand all



My primary research interests have been in and remain in translational research. Early research focused on experimental models for thrombosis research applicable to the development of a total artificial heart. Current research focuses on the development of clinically relevant translational models, both ex vivo and in vitro, that can help reduce the complexity and need for clinical research and that can be applied to comparative effectiveness research in areas of infection prevention and wound repair. Methods include the incorporation of histopathology, immunohistochemistry and other forms of in situ analysis with molecular microbiology in tissue based models particularly focused on the role of antiseptics in tissue models.

Awards & Recognition

  • Fellow, American Institute for Medical and Biological Engineers
  • Wound Healing Society Research award

Research Summary

Research Interests

Epidermal response to antiseptics; Epidermal healing (as part of wound repair)

Research Projects

Epidermal proliferation following wounding of human skin explants; Antiseptic function and biofilm prevention by antiseptic impregnated materials


  • Chong Conklin Bathsheba E. and Parks, PJ. Method of classifying chemically crosslinked cellular samples using mass spectra. US 2011/0177492 A1.
  • Anderson, M.J., Horn, M.E., Lin, Y.C., Parks, P.J., and M.L. Peterson. Efficacy of concurrent Application of Chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. Am. J. Infect. Control 2010; 38:826-831.
  • Anderson, M.J., Lin, Y.C., Gillman, A.N., Parks, P.J., Schlievert, P.M. and M.L. Peterson. Alpha-toxin promotes mucosal biofilm formation by Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology. 2012;2:64. doi: 10.3389/fcimb.2012.00064. Epub 2012 May 9
  • Anderson, M.J., Parks, P.J., and M. L. Peterson. A mucosal model to study microbial biofilm development and antibiofilm therapeutics. J. Micro. Methods 2012 Dec 14. pii: S0167-7012(12)00399-5. doi: 10.1016/j.mimet.2012.12.003. [Epub ahead of print]
  • Schuren J, Bernatchez SF, Tucker J, Schnobrich and Parks PJ. 3M™Coban 2™ Layer Compression Therapy: Intelligent compression dynamics to suit different patient needs. Adv Wound Care (2012) 3:1-4.
  • Parks PJ and Nohra GK. Surgical site infection reduction in neurosurgery: the advantage of antiseptics combined with sterile surface. Eur Neurol Rev (2010)4(2):117-121.